Medicare Enrolled

Dr. Chik-Fong Wei, M.D.

Cardiovascular Disease · Humble, TX
Low-engagement
18450 HIGHWAY 59 N, Humble, TX 77338
2814466656
In practice since 2006 (19 years)
NPI: 1508968850 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wei from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wei? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wei

Dr. Chik-Fong Wei is a cardiovascular disease in Humble, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Wei received a total of $10,520 from 40 pharmaceutical and/or device companies across 473 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wei is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $10,520 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$10,520
Total received (2018-2023)
Avg $1,753/year across 6 years
Top 30% in TX for cardiovascular disease
40
Companies
473
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,520 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$103
2022
$1,760
2021
$2,049
2020
$1,865
2019
$2,176
2018
$2,566

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,567
Abbott Laboratories
$1,389
E.R. Squibb & Sons, L.L.C.
$698
Boston Scientific Corporation
$609
Amarin Pharma Inc.
$605
Janssen Pharmaceuticals, Inc
$567
BOSTON SCIENTIFIC CORPORATION
$562
PFIZER INC.
$493
Boehringer Ingelheim Pharmaceuticals, Inc.
$470
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$424
Bard Peripheral Vascular, Inc.
$350
SANOFI-AVENTIS U.S. LLC
$325
Amgen Inc.
$324
Merck Sharp & Dohme LLC
$222
Astellas Pharma US Inc
$214
BARD PERIPHERAL VASCULAR, INC.
$205
Novo Nordisk Inc
$152
Kowa Pharmaceuticals America, Inc.
$150
Esperion Therapeutics, Inc.
$124
ABIOMED
$117
Tactile Systems Technology Inc
$117
Impulse Dynamics (USA) Inc.
$109
Cardiovascular Systems Inc.
$108
Merck Sharp & Dohme Corporation
$85
AstraZeneca Pharmaceuticals LP
$78
Medtronic Vascular, Inc.
$76
AtriCure, Inc.
$62
CVRx, Inc.
$42
Regeneron Healthcare Solutions, Inc.
$41
Actelion Pharmaceuticals US, Inc.
$40
Regeneron Pharmaceuticals, Inc.
$38
Biohaven Pharmaceutical Holding Company Ltd.
$27
BIOTRONIK INC.
$26
Aziyo Biologics, Inc.
$20
HeartFlow, Inc.
$17
CHIESI USA, INC.
$16
LeMaitre Vascular, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Allergan Inc.
$12
iRhythm Technologies, Inc.
$11
Top 3 companies account for 34.7% of total payments
Associated products mentioned in payments ›
Amplia MRI · BELSOMRA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · CRT-Ds · Confirm Rx · Connectivity and Remote care · Corlanor · ECM · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Ensite Cardiac Mapping System · FARXIGA · Flexitouch Plus · Impella · JARDIANCE · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LIFESTENT · LIFESTREAM · LUTONIX · LifeVest · Livalo · MULTAQ · Merlin Connectivity and Remote · NEXLETOL · NEXLIZET · NURTEC ODT · OPSUMIT · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · Pacemakers · Peripheral Orbital Atherectomy System · RESTOREFLO · Repatha · ULTRAVERSE · UPTRAVI · VENOVO · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · ViewFlex Xtra ICE Catheter · WATCHMAN · WATCHMAN Access System · XARELTO · XIENCE SIERRA · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease in Humble?
Compare cardiovascular diseases in the Humble area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
350
Per 100K population
7.4
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN NORTHEAST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wei is a cardiovascular disease, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Wei receive payments from pharmaceutical companies?
Yes. Dr. Wei received a total of $10,520 from 40 companies across 473 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Wei) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →